TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin

Diabetes

Volumn 56, Issue 1, 2007, Pages 49-56

  Jiang, Hongwei ^a,b   Zhu, Hanyu ^a   Chen, Xiangmei ^a   Peng, Youming ^b   Wang, Jianzhong ^a   Liu, Fuyou ^b   Shi, Suozhu ^a   Fu, Bo ^a   Lu, Yang ^a   Hong, Quan ^a   Feng, Zhe ^a   Hou, Kai ^a   Sun, Xuefeng ^a   Cai, Guangyan ^a   Zhang, Xueguang ^a   Xie, Yuansheng ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOZOCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIVISION; CELL VOLUME; CONTROLLED STUDY; CYTOTOXICITY; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULITIS; LOW DRUG DOSE; METABOLIC PARAMETERS; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; CROSSES, GENETIC; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, TRANSGENIC; REMISSION, SPONTANEOUS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33847053278     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0710     Document Type: Article

References (45)

1. Bouwens L, Rooman I: Regulation of pancreatic beta-cell mass. Physiol Rev 85:1255-1270, 2005
2. Wang RN, Bouwens L, Klöppel G: Beta cell growth in adolescent and adult rats treated with streptozotocin during the neonatal period. Diabetologia 39:548-557, 1996
3. Vasavada RC, Cavaliere C, D'Ercole AJ, Dann P, Burtis WJ, Madlener AL, Zawalich K, Zawalich W, Philbrick WM, Stewart AF: Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia. J Biol Chem 271:1200-1208, 1996
4. Garcia-Ocana A, Takane KK, Syed MA, Philbrick WM, Vasavada RC, Stewart AF: Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 275:1226-1232, 2000
5. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ: Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7:1133-1137, 2001
6. Petrik J, Pell JM, Arany E, McDonald TJ, Dean WL, Reik W, Hill DJ: Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 140:2353-2363, 1999
7. Rooman I, Bouwens L: Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57BL6/J mice treated with alloxan. Diabetologia 47:259-265, 2004
8. Li L, Yi Z, Seno M, Kojima I: Activin A and β-cellulin: effect on regeneration of pancreatic β-cells in neonatal streptozotocin-treated rats. Diabetes 53:608-615, 2004
9. Lambert E, Dasse E, Haye B, Petifrere E: TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49:187-198, 2004
10. Hornebeck W, Lambert E, Petitfrere E, Bernard P: Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie 87:377-383, 2005
11. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA, Leary AC, Brown EL, Orr EC, Clark SC: Molecular characterization and expression of the gene encoding human erythroid- potentiating activity. Nature 315:768-771, 1985
12. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318:66-69, 1985
13. Patarca R, Haseltine WA: A major retroviral core protein related to EPA and TIMP. Nature 318:390, 1985
14. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells: a possible new growth factor in serum. FEBS Lett 298:29-32, 1992
15. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L: Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97:679-685,1991
16. Fata JE, Leco KJ, Moorehead RA, Martin DC, Khokha R: Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol 211:238-254, 1999
17. Kikuchi K, Kadono T, Furue M, Tamaki K: Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol 108:281-284, 1997
18. Wang T, Yamashita K, Iwata K, Hayakawa T: Both tissue inhibitors of metalloproteinases-1 (TIMP-1) and TIMP-2 activate Ras but through different pathways. Biochem Biophys Res Commun 296:201-205, 2002
19. Zhao WQ, Li H, Yamashita K, Guo XK, Hoshino T, Yoshida S, Shinya T, Hayakawa T: Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J Cell Sci 111:1147-1153, 1998
20. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M: In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 102:2002-2010, 1998
21. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ: Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102:538-549, 1998
22. Oelmann E, Herbst H, Zuhlsdorf M, Albrecht O, Nolte A, Schmitmann C, Manzke O, Diehl V, Stein H, Berdel WE: Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 99:258-267, 2002
23. Alexander CM, Howard EW, Bissell MJ, Werb Z: Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J Cell Biol 135:1669-1677, 1996
24. Lin H, Chen X, Wang J, Yu Z: Inhibition of apoptosis in rat mesangial cells by tissue inhibitor of metalloproteinase-1. Kidney Int 62:60-69, 2002
25. Chromek M, Tullus K, Lundahl J, Brauner A: Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation. Infect Immun 72:82-88, 2004
26. Vorotnikova E, Tries M, Braunhut S: Retinoids and TIMP1 prevent radiation-induced apoptosis of capillary endothelial cells. Radiat Res 161:174-184, 2004
27. Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U, Edwards DR, Khokha R: Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 41:857-867, 2005
28. Taube ME, Liu XW, Fridman R, Kim HR: TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27(KIP1) protein. Oncogene 25:3041-3048, 2006
29. Djafarzadeh R, Noessner E, Engelmann H, Schendel DJ, Notohamiprodjo M, von Luettichau I, Nelson PJ: GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing. Oncogene 25:1496-508, 2006
30. Zhang X, Chen X, Hong Q, Lin H, Zhu H, Liu Q, Wang J, Xie Y, Shang X, Shi S, Lu Y, Yin Z: TIMP-1 promoted age-related renal fibrosis through upregulating ICAM-1 in human TIMP-1 transgenic mice. J Gerontol A Biol Sci Med Sci. In press
31. Han X, Sun Y, Scott S, Bleich D: Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and β-cells. Diabetes 50:1047-1055, 2001
32. Zhou YP, Madjidi A, Wilson ME, Nothhelfer DA, Johnson JH, Palma JF, Schweitzer A, Burant C, Blume JE, Johnson JD: Matrix metalloproteinases contribute to insulin insufficiency in Zucker diabetic fatty rats. Diabetes 54:2612-2619, 2005
33. Federici M, Hribal ML, Menghini R, Kanno H, Marchetti V, Porzio O, Sunnarborg SW, Rizza S, Serino M, Cunsolo V, Lauro D, Mauriello A, Smookler DS, Sbraccia P, Sesti G, Lee DC, Khokha R, Accili D, Lauro R: Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest 115:3494-3505, 2005
34. Dai C, Li Y, Yang J, Liu Y: Hepatocyte growth factor preserves beta cell mass and mitigates hyperglycemia in streptozotocin-induced diabetic mice. J Biol Chem 278:27080-27087, 2003
35. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol- chloroform extraction. Anal Biochem 162:156-159, 1987
36. Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA: Very slow turnover of β-cells in aged adult mice. Diabetes 54:2557-2567, 2005
37. Okamoto H, Hribal ML, Lin HV, Bennett WR, Ward A, Accili D: Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. J Clin Invest 116:775-782, 2006
38. Baik SH, Park IB, Choi KM, Kim YH, Kim NH, Kim SJ, Song GG, Choi DS: BCG vaccine prevents insulitis in low dose streptozotocin-induced diabetic mice. Diabetes Res Clin Pract 46:91-97, 1999
39. Perez SE, Cano DA, Dao-Pick T, Rougier JP, Werb Z, Hebrok M: Matrix metalloproteinases 2 and 9 are dispensable for pancreatic islet formation and function in vivo. Diabetes 54:694-701, 2005
40. Bateman AC, Turner SM, Thomas KS, McCrudden PR, Fine DR, Johnson PA, Johnson CD, Iredale JP: Apoptosis and proliferation of acinar and islet cells in chronic pancreatitis: evidence for differential cell loss mediating preservation of islet function. Gut 50:542-548, 2002
41. Descamps FJ, Van den Steen PE, Martens E, Ballaux F, Geboes K, Opdenakker G: Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin. FASEB J 17:887-889, 2003
42. Descamps FJ, Martens E, Ballaux F, Geboes K, Opdenakker G: In vivo activation of gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin-induced diabetes. J Pathol 204:555-561, 2004
43. Ryan ME, Usman A, Ramamurthy NS, Golub LM, Greenwald RA: Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity. Curr Med Chem 8:305-316, 2001
44. Rossini A, Appel MC, Williams RM, Like AA: Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes 26:916-920, 1977
45. Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, Hakem R, Ohashi PS, Woo M: Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 25:3620-3629, 2005